SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants

Marc-Antoine de La Vegaa Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USAView further author information

Efstathia Polychronopouloub Office of Biostatistics, University of Texas Medical Branch, Galveston, TX, USAView further author information

Ara XIIIa Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USAView further author information

Zhe Dingc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of China;d University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information

Tong Chenc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of China;d University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information

Qixing Liuc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of China;d University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information

Jiaming Lanc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information

Marie-Edith Nepveu-Traversye Global Urgent and Advanced Research and Development (GuardRX), Batiscan, CanadaView further author information

Hugues Fausther-Bovendoe Global Urgent and Advanced Research and Development (GuardRX), Batiscan, CanadaView further author information

Mohammed F. Zaidanf Department of Internal Medicine, Division of Pulmonary, Critical Care, & Sleep Medicine, University of Texas Medical Branch, Galveston, TX, USAView further author information

Gary Wongc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information

Gulshan Sharmag Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USAView further author information

Gary P. Kobingera Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
View further author information

show all

SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants

Citations (2)

Read on this site (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date